Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany’s Grand Coalition Offers Pharma Little Certainty, Except For Continued Discounts

This article was originally published in The Pink Sheet Daily

Executive Summary

Germany’s new grand coalition government includes a health minister with no background in health care.


Related Content

Sensing No Room For Price Compromise, Janssen Pulls Invokana From Germany
Reimbursement Deal In Germany Puts Forxiga Back On Medicine Menu
European Notebook: Price Freezes, European Elections To Feature In 2014
European Notebook: Revolutionary Change Needed for European Biotech; CHMP Releases Opinions Agenda; Growing Interest In Biosimilars
German Pharma Balks As Second HTA Retrospective Assessment Includes Orphan Drugs
Germany Cuts Pharma Rebate Level While Keeping Price Freeze
Germany's Discount Contracts Are Changing The Pharma Market Landscape


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts